Listed

Nephros Inc: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Nov 14, 2013 and accepted by EDGAR at Nov 14, 2013, 16:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-07-01 to 2013-09-30$418.0kus-gaap:SalesRevenueNet
Revenue9 months2013-01-01 to 2013-09-30$1.5mus-gaap:SalesRevenueNet
Cost of revenue3 months2013-07-01 to 2013-09-30$189.0kus-gaap:CostOfGoodsSold
Cost of revenue9 months2013-01-01 to 2013-09-30$610.0kus-gaap:CostOfGoodsSold
Gross profit3 months2013-07-01 to 2013-09-30$229.0kus-gaap:GrossProfit
Gross profit9 months2013-01-01 to 2013-09-30$904.0kus-gaap:GrossProfit
Selling, general and administrative3 months2013-07-01 to 2013-09-30$578.0kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2013-01-01 to 2013-09-30$2.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2013-07-01 to 2013-09-30−$608.0kus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30−$2.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-07-01 to 2013-09-30$5.0kus-gaap:InterestExpense
Interest expense9 months2013-01-01 to 2013-09-30$52.0kus-gaap:InterestExpense
Net income3 months2013-07-01 to 2013-09-30−$611.0kus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30−$2.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30−$0.03us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30−$0.17us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2013-01-01 to 2013-09-30−$2.9mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2013-09-30$168.0kus-gaap:Cash
Current assetsAt period end2013-09-30$600.0kus-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$2.6mus-gaap:Assets
Current liabilitiesAt period end2013-09-30$1.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-09-30$2.1mus-gaap:Liabilities
Shareholders' equityAt period end2013-09-30$430.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-13-061818. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.